(Q45888106)

17 December 2017

review article

1 reference

title

Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands (English)

1 reference

17 December 2017

1 reference

N Laytragoon-Lewin

1

1 reference

17 December 2017

publication date

1 April 1998

1 reference

17 December 2017

published in

Medical Oncology

1 reference

17 December 2017

volume

15

1 reference

17 December 2017

issue

1

1 reference

17 December 2017

page(s)

15-19

1 reference

17 December 2017

1 reference

12 December 2020

Constitutive expression of Fas (Apo-1/CD95) ligand on multiple myeloma cells: a potential mechanism of tumor-induced suppression of immune surveillance

1 reference

12 December 2020

Stimulation of protein tyrosine phosphorylation, phosphoinositide turnover, and multiple previously unidentified serine/threonine-specific protein kinases by the Pan-B-cell receptor CD40/Bp50 at discrete developmental stages of human B-cell ontogeny

1 reference

12 December 2020

Mechanism and biological significance of CD4-mediated cytotoxicity

1 reference

12 December 2020

CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

1 reference

12 December 2020

Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen

1 reference

12 December 2020

Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death

1 reference

12 December 2020

Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule

1 reference

12 December 2020

Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion?

1 reference

12 December 2020

Cytotoxicity and weak CD40 ligand expression of CD8+ type 2 cytotoxic T cells restricts their potential B cell helper activity

1 reference

12 December 2020

A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas

1 reference

12 December 2020

gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory

1 reference

12 December 2020

Concurrent engagement of CD40 and the antigen receptor protects naive and memory human B cells from APO-1/Fas-mediated apoptosis

1 reference

12 December 2020

T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death

1 reference

12 December 2020

CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated p

1 reference

12 December 2020

Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide

1 reference

12 December 2020

Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40

1 reference

12 December 2020

Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome

1 reference

12 December 2020

Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and costimulation with IL-4 and the differentiation factors IL-2, IL-10, and IL-3.

1 reference

12 December 2020

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand

1 reference

12 December 2020

Characterization of apoptosis-resistant antigen-specific T cells in vivo

1 reference

12 December 2020

APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.

1 reference

12 December 2020

CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway

1 reference

12 December 2020

Regulation of apoptosis in the immune system

1 reference

12 December 2020

Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens

1 reference

12 December 2020

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

12 December 2020

Melanoma cell expression of Fas(Apo-1/CD95) ligand: implications for tumor immune escape

1 reference

12 December 2020

1 reference

12 December 2020

The biology of the human ligand for CD40.

1 reference

12 December 2020

Isolated human follicular dendritic cells display a unique antigenic phenotype

1 reference

12 December 2020

Essential roles of the Fas ligand in the development of hepatitis

1 reference

12 December 2020

Local Fas/APO-1 (CD95) ligand-mediated tumor cell killing in vivo

1 reference

12 December 2020

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines

1 reference

12 December 2020

Fas antigen/APO-1 (CD95) expression on myeloma cells

1 reference

12 December 2020

The CD40 antigen and its ligand

1 reference

12 December 2020

Molecular and biological characterization of a murine ligand for CD40

1 reference

12 December 2020

Mechanism of antigen-driven selection in germinal centres

1 reference

12 December 2020

An aggressive nasal lymphoma accompanied by high levels of soluble Fas ligand

1 reference

12 December 2020

Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice

1 reference

12 December 2020

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 reference

12 December 2020

Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis

1 reference

12 December 2020

Immunodeficiency with hyper-IgM (HIM)

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02787339

1 reference

17 December 2017

Dimensions Publication ID

1013680391

0 references

1 reference

17 December 2017